LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10056-1 | Selumetinib | AZD6244; Array142886 | LSM-1056 | 10127622 | |
10045-1 | A443654 | LSM-1045 | 10172943 | ||
10035-1 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 | 10196499 | |
10032-1 | Saracatinib | AZD0530 | LSM-1032 | 10302451 | |
10040-1 | R406 | LSM-1040 | 11213558 | ||
10061-1 | NU7441 | KU 57788 | LSM-1061 | 11327430 | |
10004-1 | AT-7519 | LSM-1004 | 11338033 | ||
10041-1 | BI-2536 | NPK33-1-98-1 | LSM-1041 | 11364421 | |
10177-1 | Brivanib | BMS-540215 | LSM-1178 | 11451527 | |
10122-1 | NVP-AEW541 | AEW541 | LSM-44953 | 11476171 | |
10182-1 | Linifanib | ABT-869; AL-39324 | LSM-1183 | 11485656 | |
10116-1 | PF431396 | LSM-1116 | 11598628 | ||
10027-1 | Crizotinib | PF02341066 | LSM-1027 | 11626560 | |
10135-1 | Linsitinib | OSI 906 | LSM-1135 | 11640390 | |
10053-1 | ZSTK474 | LSM-1053 | 11647372 | ||
10142-1 | Trametinib | GSK-1120212; GSK1120212; GSK1120212B; JTP-74057 | LSM-1143 | 11707110 | |
10072-1 | PF562271 | KIN001-205 | LSM-1072 | 11713159 | |
10055-1 | BX-912 | LSM-1055 | 11754511 | ||
10232-1 | Dactolisib | BEZ235; NVP-BEZ235 | LSM-4255 | 11977753 | |
10098-1 | Gefitinib | ZD1839; Iressa | LSM-1098 | 123631 | |
10026-1 | PD173074 | LSM-1026 | 1401 | ||
10120-1 | Canertinib | CI-1033; PD-183805 | LSM-1120 | 156414 | |
10067-1 | Barasertib | AZD1152-HQPA | LSM-1067 | 16007391 | |
10001-1 | Seliciclib | (R)-Roscovitine; CYC202 | LSM-1001 | 160355 | |
10024-1 | NVP-TAE684 | TAE-684 | LSM-1024 | 16038120 |